u/aksel_kjaer

Push back: "gentler than sema" is a population statement. Plenty of people on this board have the opposite experience and they are not doing it wrong.

Right — GL Biochem answered a handling question with actual storage conditions rather than a generic line, which is the standard.

Compared milligram figures across two completely different molecule classes in a comment. Deserved the correction.

Research-use-only material is not approved for human use. Anything in this thread about how a research vial "should" titrate is a discussion about chemistry, not a plan.

a single DEXA is a number, two is a comparison, three is a trend

Small fix — 214nm, not 210. It matters for the comparison you are making with the other run.

Small fix — the two programme names got swapped upthread and it changes which population the figure came from.

The 21% figure is a 72-week mean on the highest arm. Quoting it as what someone should expect by week 83 is not a fair reading.

Bought a second-hand instrument and learned more in six months of fixing it than in three years of reading traces.

Small fix — 214nm, not 210. It matters for the comparison you are making with the other run.

Same method at both labs, or two different gradients?

DEXA has a real error margin and people quote it to one decimal

if 7.5 is working, 10 is not automatically better

Milligram comparisons across molecule classes are meaningless. Potency is a property of the molecule at its receptor, not of the number on the label.

What did the tolerability table look like at that dose?

Can you post the trace with the axes labelled?

This. The absence of food and water timing restrictions is the practical difference people will actually notice.

Careful — you are treating retention time as identity. Two things can co-elute and the trace will not tell you.

Analytically this is a small-molecule identity and purity problem, not a peptide one. The methods, the impurity classes and the reference standards are all different.

retention time alone is not identity

Agreed — non-peptide is the fact that everything else follows from, including the manufacturing and the analytics.

Small fix — 214nm, not 210. It matters for the comparison you are making with the other run.

The distribution matters more than the mean. In the trial population the interquartile spread was wide enough that two honest people can have completely different runs on the same arm.

Area percent is the integrated area of your peak over the total integrated area at one wavelength on one gradient. Change any of those and the number changes without the sample changing.

Appetite effect for me is flat across seven days. On sema it was a wave. Same person, different molecule.

System suitability — repeat injections, tailing factor, plate count, RSD on area — is what tells you the instrument was fit for the measurement that day. Without it, the purity figure is unanchored.

2.5 is the starter dose and it is not meant to be the dose that works

Right. And the sema-to-tirz "conversion" people post is invented. There is no published equivalence.

Push back: "gentler than sema" is a population statement.

sten_bhattacharya is right that the two molecules are not interchangeable. There is no published conversion and the ones circulating are invented.

Are you comparing yourself with the trial mean or with the people who post the most?

Sulphur burps for the first eight days after each step, then nothing. Predictable enough that I planned my week around it.

Weekly dosing again, half-life in the same neighbourhood as sema, so a step change takes about a month to reach steady state.

Saving this one. It is the clearest statement of the stall problem I have read here.

Not sure that follows.

This. The step interval is a floor, and reading it as a timetable is the most expensive mistake in the thread.